The FDA granted a De Novo request for DreaMed Diabetes’ artificial intelligence-based decision support software Advisor Pro, the Israeli diabetes management solutions developer confirmed June 18.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback